EMBL Australia

The international research community is collaborating on a scale and at a speed never seen before to battle COVID-19 and EMBL Australia group leaders have answered the call to help.

EMBL Australia group leader Professor David Lynn will be the interim director of a new $7 million state-of-the-art centre for genomics in South Australia that he played a vital role in championing.

Professor David Lynn is an EMBL Australia Group Leader, based at the South Australian Health and Medical Research Institute (SAHMRI), and a Flinders University Professor.

EMBL Australia group leader Max Cryle has provided a new understanding of Glycopeptide antibiotics (GPAs) biosynthesis that allows new GPAs to be made and tested in the laboratory - a vital step in the quest to develop new antibiotics to keep pace with the ever-evolving ‘superbugs’ that threaten global public health.

An opinion article by EMBL Australia Scientific Head Professor James Whisstock (published in The Herald Sun on 13 May 2020) calls for a national approach for funding a diversity and depth of scientific research we hope we might never need.

EMBL Australia group leader Professor Eduardo Eyras has developed a general-purpose tool to study how cells function in a common type of brain tumour, but that could also be applied to other tumours and diseases. The research was published in Nature Communications.

PhD student Ebony Monson received a $2000 EMBL Australia travel grant last year, which helped with her ticket to Europe, new networks, potential collaborations and a whole lot of new ideas for the future direction of her novel research.

EMBL Australia group leader Dr Robert Weatheritt was co-awarded a $470,000 ARC Discovery Project grant to study the biogenesis and function of circular RNAs in the brain. The exciting international collaboration begins later this month.

An international team of researchers, co-led by EMBL Australia group leader Dr Richard Morris, has revealed the mechanisms behind fish schooling – and what they found differs from what scientists had previously thought.

An international consortium of researchers, led by EMBL Australia group leader Professor David Lynn, has painstakingly mapped an intracellular network that could open the door to discovering new targeted treatments for colorectal cancer.